See All Slides - tctmd.com

Slides

Presentation TCT 2012

CCTRN: Second Cycle Studies

Presenter: Emerson Perin

October 22, 2012

Presentation TCT 2012

TVT Goes Viral: New Valve Systems and Accessory Devices Will Transform the Future

Presenter: Eberhard Grube

October 22, 2012

Presentation TCT 2012

The Art and Science of Risk Stratification in Aortic Stenosis: Updates on Risk Scores, Futility, and Other Imponderables

Presenter: Michael Mack

October 22, 2012

Presentation TCT 2012

My Criteria for Selecting Transapical TAVR (vs. Transfemoral TAVR or Open Surgery)

Presenter: Rudiger Lange

October 22, 2012

Presentation TCT 2012

Position 4. Patient Preference Matters: Use PCI with DES Early and Liberally in Most Patients!

Presenter: Ajay Kirtane

October 22, 2012

Presentation TCT 2012

New Pacemakers After TAVR: Frequency, Predictors, Clinical Outcomes, and Guidelines on “When to Treat”

Presenter: Jeffrey Popma

October 22, 2012

Presentation TCT 2012

Debate I. Are Drug-Eluting Stents Now the Default Strategy for SFA Intervention? - Pro!

Presenter: Gary Ansel

October 22, 2012

Presentation TCT 2012

The Epidemiology of Valvular Aortic Stenosis in the 21st Century

Presenter: Vuyisile Nkomo

October 22, 2012

Presentation TCT 2012

Updates from the Worldwide Valve-in-Valve TAVR Registry

Presenter: Danny Dvir

October 22, 2012

Presentation TCT 2012

Improved Patient Screening, Meticulous Access and Closure Techniques, and Lower Profile Catheter Systems Can Reduce Major Vascular Complications to <5%: The Vancouver Experience

Presenter: John Webb

October 22, 2012

Advertisement

Slides

CCTRN: Second Cycle Studies

TVT Goes Viral: New Valve Systems and Accessory Devices Will Transform the Future

The Art and Science of Risk Stratification in Aortic Stenosis: Updates on Risk Scores, Futility, and Other Imponderables

My Criteria for Selecting Transapical TAVR (vs. Transfemoral TAVR or Open Surgery)

Position 4. Patient Preference Matters: Use PCI with DES Early and Liberally in Most Patients!

New Pacemakers After TAVR: Frequency, Predictors, Clinical Outcomes, and Guidelines on “When to Treat”

Debate I. Are Drug-Eluting Stents Now the Default Strategy for SFA Intervention? - Pro!

The Epidemiology of Valvular Aortic Stenosis in the 21st Century

Updates from the Worldwide Valve-in-Valve TAVR Registry

Improved Patient Screening, Meticulous Access and Closure Techniques, and Lower Profile Catheter Systems Can Reduce Major Vascular Complications to <5%: The Vancouver Experience

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content